NEPHROLOGY & TRANSPLANTATION UPDATE COURSE
28th & 29th November 2020

Registration to the online Nephrology & Transplantation Update Course includes access to the full program below, the Meeting Hub, Exhibition Lounge and all virtual networking sessions. Unless otherwise indicated all sessions will be recorded and available to watch on-demand for two weeks after the conclusion of the event. 

Registration to the Update Course is separate to the main ANZSN ASM and is an additional cost to attend. 

Click here to register.

Program times are listed in AEDST. To convert program times to your timezone, CLICK HERE

Saturday, 28th November 2020
0830-0900
SPEED NETWORKING ICEBREAKER
Take this opportunity to network with colleagues, sponsors and speakers. Participants will be randomly allocated through a series of four-person 2-3 minute video chats.  You never know who you might meet!
0900-1130
ADVANCES IN NEPHROLOGY IN 2020

At the dawn of 2020, Nephrology fields have made several breakthroughs that include but not limited to the followings: 1) After nearly two decades, a new agent, sodium–glucose cotransporter 2 (SGLT2) inhibitor is proven to prevent loss of kidney function, end-stage kidney disease, hospitalisation for heart failure and cardiovascular death in patients with Diabetic Kidney Disease (DKD); 2) New discovery has provided an approved treatment to slow the growth of cysts and to preserve kidney function of the most common inherited kidney disease, Autosomal Dominant Polycystic Kidney Disease (ADPKD), 3) Several milestones have been made in management of anemia in Chronic Kidney Disease (CKD) with emerging efficacy and safety evidence of orally available HIF-1a stabilizers, 4) Technical advances in genome sequencing and association studies have yielded critical insights into the genetic architecture of kidney diseases that improve our understanding of the mechanisms of kidney development, homeostasis and disease states, many of which have clinical implications.

Learning objective(s):

  • To promote understanding and clinical knowledge in the recent advances in the field of nephrology.
  • To outline the current available evidence and gaps in knowledge with the view to promote future research.

ADVANCE IN MANAGEMENT OF DIABETIC KIDNEY DISEASE (DKD)

Meg Jardine, Nephrologist, Concord Repatriation Hospital, The George Institute and UNSW Sydney

ADVANCE IN MANAGEMENT OF ANAEMIA IN CHRONIC KIDNEY DISEASE (CKD)

Simon Roger, Nephrologist, University of Newcastle and Gosford Hospital

ADVANCES IN GENETICS IN NEPHROLOGY

Amali Mallawaarachchi, Nephrologist, Royal Prince Alfred Hospital

BREAKTHROUGH IN MANAGEMENT OF PKD – ADPKD AND ARPKD

Lisa Guay-Woodford, Nephrologist, Children’s National Medical Center (CNMC), Washington

DISCUSSION TIME
1130-1200
EXHIBITION & REFRESHMENT BREAK
Visit our sponsors in the Exhibition Lounge or catch up with colleagues through the Meeting Hub
1200-1530
GENERAL NEPHROLOGY
With the program going completely virtual in 2020, we have created 5 concurrent sessions providing the latest updates in general nephrology under the following five subthemes. A mixture of local, regional and international speakers will cover topics that are bread and butter for your clinical practice including glomerulonephritis, acute and chronic kidney disease as well as the hot topic of COVID-19 and the kidneys. The second half of the Interventional Nephrology (combined ANZSIN-ANZSN) and Genetic / Paediatric (Combined KidGen-ANZSN sessions) consist of interactive workshops facilitate by the field experts giving you the best experience in translation medicine.
Don’t stress if you can’t attend every session. All sessions (unless otherwise indicated) will be recorded and shared with participants after the course.
1200-1400
CONCURRENT SESSIONS

Each sessions consists of minimum three speakers and includes question time.  Participants may attend any session without pre-booking.  All presentations, unless otherwise indicated, will be available on-demand to registered participants for a limited time after the course.
GLOMERULONEPHRITIS ACUTE KIDNEY INJURY CHRONIC KIDNEY DISEASE INTERVENTIONAL NEPHROLOGY – ANZSIN / ANZSN combined session PAEDIATRIC / GENETIC NEPHROLOGY – KidGen / ANZSN combined session

UPDATE IN LUPUS NEPHRITIS

Daniel Chan, Nephrologist, Chief of Nephrology Division.
Chief of Nephrology, University of Hong Kong and Hong Kong West Cluster Hospitals

IS SODIUM CHLORIDE THE BEST REPLACEMENT FLUID?

Michael Collins, Nephrologist, Auckland City Hospital

DOSE AND FREQUENCY OF DIALYSIS – WHICH IS MORE IMPORTANT?

Lorraine Kwan, Nephrologist, Queen Mary Hospital and Tung Wah Hospital

[APSN Speaker]

UPDATE IN HD ACCESS IN 2020

Andrea Viecelli, Nephrologist, Princess Alexandra Hospital and University of Queensland

HYPERTENSION AND PROGRESSION OF CKD IN CHILDREN

Joseph T Flynn, Nephrologist, Washington DC

NOVEL THERAPY IN IGA NEPHROPATHY

Yusuke Suzuki, Nephrologist, Juntendo University

[APSN Speaker]

LONG TERM SEQUELAE OF ACUTE KIDNEY INJURY

Emily See, Critical Care Nephrologist, Austin Health

ADVANCES IN IMAGING IN CKD

Patrick (Paddy) Mark, Consultant Nephrologist, Queen Elizabeth University Hospital Glasgow

ENVIRONMENTALLY FRIENDLY PD

Steve May

UPDATE ON NEPHROTIC SYNDROME IN CHILDREN

Rachael Kermond, Advanced Paediatric Nephrology Trainee, Royal Children’s Hospital, Melbourne

UPDATE IN MANAGEMENT OF ANCA VASCULITIS

Robyn Langham

DIAGNOSIS AND MANAGEMENT OF CARDIORENAL SYNDROME

Nathan Dwyer, Cardiologist, Royal Hobart Hospital

UPDATE IN PERITONEAL DIALYSIS

Sunita Bavanandan, Head of Department, Hospital Kuala Lumpur

[APSN Speaker]

RECURRENT CEPHALIC ARCH STENOSIS: RISK FACTORS AND BEST OPTIONS FOR MANAGEMENT

Yong-Soo Kim,  Nephrologist, Catholic University of Korea College of Medicine

UPDATE ON UTIs IN PAEDIATRICS

Laila Ibrahim, Murdoch Children’s Research Institute

REFRESHMENT BREAK
Take a break, have a stretch, visit the sponsors in the Exhibition Lounge, or connect with a colleague in the Meeting Hub.
1400-1530
CONCURRENT SESSIONS

Each sessions consists of minimum three speakers and question time. Participants may attend any session without pre-booking.  
GLOMERULONEPHRITIS ACUTE KIDNEY INJURY CHRONIC KIDNEY DISEASE (CKD) INTERVENTIONAL NEPHROLOGY – ANZSIN / ANZSN combined session PAEDIATRIC / GENETIC NEPHROLOGY – KidGen / ANZSN combined session

ROLE OF B CELL THERAPY IN GLOMERULONEPHRITIS

Holly Hutton

POTASSIUM, SODIUM, AND ADRENALS – TOO EASY? TOO HARD?

Amanda Mather, Nephrologist, Royal North Shore Hospital and University of Sydney

CONSERVATIVE CARE IN PATIENTS WITH CHRONIC KIDNEY DISEASE

Raj Rajesh, Nephrologist, Launceston General Hospital

CARI GUIDELINES FOR KIDNEY BIOPSY

Jeff Wong

GENETIC WORKSHOP 101

Patients with genetic kidney disease benefit from a multidisciplinary approach to assessment and testing. At this workshop you will be taken through worked clinical cases by a team of clinical geneticists, nephrologists and genetic counsellors who will draw on their clinical experience to demonstrate the power of the team based approach. Participants will be introduced to clinical assessment, testing modalities, genomic interpretation, counselling and cascade testing.

 

 

ROLE OF ENDOTHELIN RECEPTOR ANTAGONIST IN PROTEINURIC KIDNEY DISEASE

Muh Geot Wong, Nephrologist, Royal North Shore Hospital, University of Sydney and UNSW

UPDATE IN ACUTE INTERSTITIAL NEPHRITIS

Robert MacGinley

ASSESSMENT FRAILTY IN PATIENTS WITH CKD – WHAT, WHEN AND HOW?

Kathryn Ducharlet

IMMATURE FISTULA: CHARACTERISTICS AND OUTCOMES OF ENDOVASCULAR SALVAGE

Yong-Soo Kim, Nephrologist, Catholic University of Korea College of Medicine

PROTEINURIA AS SURROGATE MARKERS FOR GLOMERULAR DISEASE – TRUTH OR MYTH?

Speaker to be advised

COVID 19 AND KIDNEYS

Vivekanand Jha, Nephrologist, The George Institute for Global Health

ROLE OF POTASSIUM AND UREMIC BINDER IN MANAGEMENT OF CKD

Suet Wan Choy, Nephrologist, Austin Health

POINT OF CARE ULTRASOUND

Tim Spicer

DAY ONE CONCLUDES
Sunday, 29th November 2020
0830-0900
SPEED NETWORKING ICEBREAKER
Take this opportunity to meet colleagues, sponsors and speakers through small group meetings. Participants will be randomly allocated through a series of four-person 2-3 minute video chats.  You never know who you might meet!
TRANSPLANTATION – TSANZ / ANZSN combined

Kidney transplantation is considered the treatment of choice for individuals with severe chronic kidney disease due to improved quality of life and survival when compared to individuals receiving dialysis. This half-day session is a combined effort of TSANZ and ANZSN in providing essential updates on relevant topics for non-transplant nephrologists. This session covers relevant topics in kidney transplantation for donor and recipient perspective, from pre-transplant assessment to post-transplant management as well as the paired kidney exchange program. 

Learning objective(s):

  • To promote understanding and clinical knowledge in advances in kidney transplantation for non-transplant physicians.
  • To outline the current available evidence and gaps in knowledge with view to promote future research directions.
    • The virtual case group discussion with covers clinical scenarios commonly encounter by non-transplant nephrologists while caring for your patients with kidney transplantation.
0900-0930
WHAT DID WE LEARN IN 2020?

ADVANCES IN KIDNEY TRANSPLANTATION IN 2020

Jeremy Chapman

0930-1130
PRE-TRANSPLANT

PRE-TRANSPLANT IMMUNOLOGICAL ASSESSMENT AND MANAGEMENT

Natasha Rogers, Nephrologist, Westmead Clinical School

FRAILTY IN KIDNEY TRANSPLANTATION – WHEN TO SAY NO?

Wai Lim, Nephrologist, Sir Charles Gairdner Hospital

PRE-TRANSPLANT MANAGEMENT OF OVERWEIGHT/OBESITY IN POTENTIAL KIDNEY RECIPIENT

Amanda Robertson, Transplant Surgeon, The Royal Melbourne Hospital

CONTROVERSIES IN LIVING DONATION/HIGH RISK KIDNEY DONATION

Speaker to be advised

1130-1200
EXHIBITION & REFRESHMENT BREAK
Visit our sponsors in the Exhibition Lounge or catch up with colleagues through the Meeting Hub

1200-1400
POST-TRANSPLANT

ACUTE AND CHRONIC ANTIBODY MEDIATED REJECTION – WHAT SHOULD YOU KNOW?

Susan Wan, Nephrologist, Royal North Shore Hospital and RPA Hospital, University of Sydney

POST-TRANSPLANT RECURRENCE OF PRIMARY DISEASE INCLUDING AHUS

Steve Chadban, Nephrologist, Charles Perkins Centre, University of Sydney

KIDNEY TRANSPLANT HISTOLOGY 101

Brian Nankiviel, Nephrologist, Westmead Hospital, Sydney

PAIRED KIDNEY EXCHANGE PROGRAM REVIEW

Stella McGinn, Nephrologist, Royal North Shore Hospital

1400-1445
VIRTUAL CASE STUDY GROUPS

Interpretation challenges faced by non transplant nephrologists.

DAY TWO CONCLUDES

About ANZSN

The ASM is hosted by Australian and New Zealand Society of Nephrology.

The aims of the Society are to promote and support the study of the kidney and urinary tract in health and disease, and to ensure the highest professional standards for the practice of nephrology in Australia and New Zealand.

Conference Managers

Please contact the team at Conference Design with any questions regarding the Annual Scientific Meeting

© 2015 - 2016 Conference Design Pty Ltd